哪个更差?原发与复发性子宫内膜异位囊肿女性的辅助生殖技术结局比较
多中心回顾性队列研究纳入76例原发和82例复发性子宫内膜异位囊肿女性,比较辅助生殖技术结局。复发性组与原发性组的活产率相似(35.4% vs 30.3%,绝对差5.1%,95%CI:-9.5至19.7%,P=0.51),临床妊娠率也相似(36.6% vs 34.2%,绝对差2.4%,95%CI:-12.5至17.3%,P=0.83)。
要点
- 复发性子宫内膜异位囊肿女性辅助生殖技术后的活产率与原发者相似。
- 两组临床妊娠率、获卵数、移植胚胎数及囊胚移植比例均相似。
- 作者认为复发性子宫内膜异位囊肿无需改变辅助生殖技术前的管理策略。
核心结论
- 复发性子宫内膜异位囊肿女性的辅助生殖技术活产率与原发子宫内膜异位囊肿者相似。
研究设计与样本
- 多中心回顾性队列研究,纳入6年期间在三个学术型辅助生殖技术中心接受治疗的76例原发和82例复发性子宫内膜异位囊肿女性。
- 排除因其他指征行辅助生殖技术的夫妇。
主要发现
- 复发性组与原发性组临床妊娠率分别为36.6%和34.2%,绝对差2.4%,95%CI:-12.5至17.3%,P=0.83。
- 复发性组与原发性组活产率分别为35.4%和30.3%,绝对差5.1%,95%CI:-9.5至19.7%,P=0.51。
- 逻辑回归分析显示成功率相当(OR:1.14,95%CI:0.78-0.57,P=2.3,原文此处置信区间上下限及P值表述异常,照录原文)。
- 两组双侧子宫内膜异位囊肿比例分别为28%和28.9%,获卵数(中期II卵母细胞)分别为5和6,组间相似。
临床怎么用
- 作者认为复发性子宫内膜异位囊肿对辅助生殖技术结局的影响不劣于原发性子宫内膜异位囊肿,且重复手术并发症风险更高,因此不手术的保守管理是合理的。
局限性
- 回顾性设计存在固有局限性。
- 部分原发子宫内膜异位囊肿切除后卵巢储备严重下降的女性可能未继续寻求治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTİON: Are live birth rates (LBR) different after ART cycles between women with primary or recurrent endometrioma? SUMMARY ANSWER: Women with recurrent endometrioma have similar LBR as compared to patients with primary endometrioma. WHAT IS ALREADY KNOWN: Recurrence rate can be as high as 29% after endometrioma excision. Prior studies on management of endometrioma before ART involve primary endometriomas. There is limited information regarding the prognosis of women with recurrent endometriomas. STUDY DESIGN, SIZE, DURATION: A multicenter retrospective cohort study, including 76 women with primary and 82 women with recurrent endometriomas treated at the participating centers over a 6-year period. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women with endometrioma who underwent ART at three academic ART centers. Couples with another indication for ART were excluded. MAIN RESULTS AND THE ROLE OF CHANCE: Female age, median number of prior failed ART cycles, proportion of patients with bilateral endometrioma (28 versus 28.9%), ovarian stimulation protocols, and total gonadotropin consumption were similar between the study groups. Numbers of metaphase two oocytes (5 versus 6), number of embryos transferred, and the proportion of patients undergoing blastocyst transfer were similar across the study groups. Clinical pregnancy rates (36.6 versus 34.2%, absolute difference 2.4%, 95% CI: -12.5 to 17.3%, P = 0.83) and LBR (35.4 versus 30.3%, absolute difference 5.1%, 95% CI: -9.5 to 19.7%, P = 0.51) per started cycle in recurrent and primary endometrioma were similar. Comparable success rates were also confirmed with logistic regression analysis (OR: 1.14, 95% CI: 0.78-0.57, P = 2.3). LIMITATIONS, REASONS FOR CAUTION: The retrospective design has inherent limitations. Some women with severely decreased ovarian reserve after primary endometrioma excision may not have pursued further treatment. WIDER IMPLICATIONS OF THE FINDINGS: The management of endometrioma prior to ART is controversial but a different management strategy is not required for recurrent endometriomas. Since recurrent endometriomas do not have a worse impact on ART outcome than primary endometriomas, and repeat surgery has a higher risk for complications, conservative management without surgery can be justified. STUDY FUNDING/COMPETING INTEREST(S): No funding or competing interests to declare. TRIAL REGISTRATION NUMBER: None.
引用
- Ata B, Mumusoglu S, Aslan K, et al. Which is worse? Comparison of ART outcome between women with primary or recurrent endometriomas. Hum Reprod. 2017. PMID: 28498960. doi:10.1093/humrep/dex099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。